Pain Over Two Years After Start of Biologic Versus Conventional Combination Treatment in Early Rheumatoid Arthritis: Results From a Swedish Randomized Controlled Trial,Arthritis Care & Research

当前位置： X-MOL 学术 › Arthritis Care Res. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Pain Over Two Years After Start of Biologic Versus Conventional Combination Treatment in Early Rheumatoid Arthritis: Results From a Swedish Randomized Controlled Trial
Arthritis Care & Research ( IF 3.7 ) Pub Date : 2020-05-20 , DOI: 10.1002/acr.24264
Tor Olofsson ₁ , Johan K Wallman ₁ , Anna Jöud ₂ , Maria E C Schelin ₂ , Sofia Ernestam ₃ , Ronald van Vollenhoven ₄ , Saedis Saevarsdottir ₅ , Jon Lampa ₄

Affiliation

To compare the pain course between methotrexate (MTX)-refractory early rheumatoid arthritis (RA) patients randomized to infliximab (IFX) versus sulfasalazine (SSZ) plus hydroxychloroquine (HCQ).

中文翻译：